An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)

PHASE2TerminatedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

January 24, 2018

Primary Completion Date

December 13, 2019

Study Completion Date

December 13, 2019

Conditions
Progressive Supranuclear Palsy (PSP)
Interventions
DRUG

ABBV-8E12

Participants with 44-49 kg body weight (BW) had an intravenous infusion rate of 3.5 mL/min or 210 mL/hr; those with 50-58 kg BW, 4.0 mL/min or 240 mL/hr; and those with a BW \>59 kg, 4.7 mL/min or 282 mL/hr.

DRUG

Placebo solution for IV infusion on Day 15

0.9% NaCl injection/solution for infusion 500 mL; participants with 44-49 kg body weight (BW) had an intravenous infusion rate of 3.5 mL/min or 210 mL/hr; those with 50-58 kg BW, 4.0 mL/min or 240 mL/hr; and those with a BW \>59 kg, 4.7 mL/min or 282 mL/hr.

Trial Locations (42)

3004

Alfred Hospital /ID# 165454, Melbourne

4006

Q-Pharm Pty Limited /ID# 165452, Herston

5000

Royal Adelaide Hospital /ID# 165451, Adelaide

30126

IRCCS San Camillo /ID# 201229, Venice

32224

Mayo Clinic /ID# 165554, Jacksonville

32607

UF Center for Movement Disorde /ID# 165561, Gainesville

33612

University of South Florida /ID# 165556, Tampa

35294

Univ Alabama-Birmingham /ID# 165522, Birmingham

40536

University of Kentucky Chandler Medical Center /ID# 165566, Lexington

44195

Cleveland Clinic Main Campus /ID# 165537, Cleveland

46202

Indiana University /ID# 165519, Indianapolis

60612

Rush University Medical Center /ID# 165527, Chicago

60637

University of Chicago Medical /ID# 165555, Chicago

77054

McGovern Medical School /ID# 165565, Houston

85054

Mayo Clinic Arizona /ID# 165521, Phoenix

86077

Istituto Neuro Mediterraneo IR /ID# 165533, Pozzilli

88100

University of Catanzaro /ID# 170214, Catanzaro

89106

Cleveland Clinic Lou Ruvo Cent /ID# 165538, Las Vegas

90033

Usc /Id# 165529, Los Angeles

90095

University of California, Los Angeles /ID# 165669, Los Angeles

90211

Cedars-Sinai Medical Center /ID# 165567, Beverly Hills

92037

University of California, San /ID# 165560, San Diego

4658620

National Hospital Organization Higashinagoya National Hospital /ID# 208786, Nagoya

94143-2204

Univ California, San Francisco /ID# 165553, San Francisco

80113-2736

Rocky Mountain Movement Disorders Center /ID# 165559, Englewood

30912-0004

Augusta University Medical Center /ID# 165562, Augusta

55905-0001

Mayo Clinic - Rochester /ID# 165518, Rochester

08901

Rutgers Robert Wood Johnson /ID# 165526, New Brunswick

10032-3725

Columbia Univ Medical Center /ID# 165528, New York

37232-0011

Vanderbilt Univ Med Ctr /ID# 165520, Nashville

75231-4316

Kerwin Research Center /ID# 206872, Dallas

T2N 4Z6

University of Calgary /ID# 165667, Calgary

M5T 2S8

Toronto Western Hospital /ID# 165462, Toronto

H2X 0A9

CHUM - Notre-Dame Hospital /ID# 165461, Montreal

H3A 2B4

Montreal Neurological Institut /ID# 165546, Montreal

00168

Policlinico Agostino Gemelli /ID# 165536, Rome

05100

A.O. Santa Maria /ID# 165535, Terni

070-8644

National Hospital Organization Asahikawa Medical Center /ID# 208818, Asahikawa

616-8255

National Hospital Organization Utano National Hospital /ID# 208780, Kyoto

982-8555

NHO Sendai Nishitaga National Hospital /ID# 209014, Sendai

565-0871

Osaka University Hospital /ID# 208787, Suita-shi

187-8551

National Center of Neurology and Psychiatry /ID# 208820, Kodaira

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY